Injectable Drug Delivery Market Share, Size, Forecast and Trends by 2021 | Research Cosmos

24/gen/2018 12:46:27 Research Cosmos Contatta l'autore

Questo comunicato è stato pubblicato più di 6 mesi fa. Le informazioni su questa pagina potrebbero non essere attendibili.

In this region, global injectable drug delivery is projected to reach USD 789.7 billion by 2024 from USD 330.6 billion in 2016, at a CAGR of 11.5% in the forecast period 2017 to 2024.

 

Based on geography, the Global Injectable Drug Delivery Market is segmented into 5 geographical regions, such as,

 

North America,

South America,

Europe,

APAC,

MEA,

 

Explore More Information about report @ https://www.researchcosmos.com/reports/injectable-drug-delivery-market-analysis-global-industry-outlook-and-forecast-2017-to-2024/625799022

 

Global injectable drug delivery market competition by top players including –

 

Becton Dickinson and company is going to dominate the injectable drug delivery market following with Pfizer and Baxter International, Inc., along with others such as

Gerresheimer AG,

Schott AG,

Alkermes Plc.,

Eli Lilly and Company,

Sandoz,

Terumo Corporation,

Teva Pharmaceuticals Industries Ltd.,

Bespak, Antares Pharma,

Elcam Medical,

Haselmeier,

Mylan N.V.,

Novo Nordisk,

Owen Mumford Ltd,

Sanofi,

West Pharmaceutical Services, Inc,

Ypsomed Holding AG.

 

Request free sample @ https://www.researchcosmos.com/request/625799022

 

The global injectable drug delivery market is segmented on the basis of type, product type, and application, and usage pattern, mode of administration, end user, distribution channel, and geography.

 

The global injectable drug delivery market is segmented into 2 types, namely injectable drug delivery device and injectable drug delivery formulation.

 

Injectable drug delivery device market is segmented into conventional injection devices and self-injection devices.

 

Inquire before buying @ https://www.researchcosmos.com/inquire/625799022

 

The injectable drug delivery formulation is segmented into conventional drug delivery formulation and novel drug delivery formulation.

 

On the basis of application, the market is segmented into autoimmune disease, hormonal disorders, orphan diseases, oncology and others.

 

The autoimmune diseases segment is further sub segmented based on indications into rheumatoid arthritis, multiple sclerosis, Crohn’s disease, psoriasis and others.

 

Hormonal disorders are further segmented into indications such as diabetes, antithrombotic therapy, reproductive health diseases, anemia, osteoporosis and others.

 

Check for discount @ https://www.researchcosmos.com/discount/625799022

 

On the basis of usage pattern, the market is segmented into curative care, immunization and other usage pattern.

 

On the basis of mode of administration, the market is segmented into skin, circulatory/muskoskeletal, organs and central nervous system.

 

On the basis of end users, the market is classified into hospitals and clinics, home healthcare, research laboratories, pharmaceutical and biotechnological companies and others.

 

About Us:

Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.

 

Contact:

Dani Rodriguez

Partner Relation Executive

Research Cosmos

Direct Line: +1 888 709 8757

Mail: dani@researchcosmos.com

 

www.researchcosmos.com

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl